Last updated: October 12, 2023
Sponsor: AstraZeneca
Overall Status: Active - Recruiting
Phase
3
Condition
N/ATreatment
N/AClinical Study ID
TX319897
Ages 12-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria
- Participants Must be at Least 12- 80 Years of Age.
- Participants Must be on a Stable Daily ICS/LABA Regimen for at Least 4 Weeks.
- Participants Must have a documented history of physician-diagnosed asthma for at least 1 year.
- Current smokers, former smokers with >10 pack-years history, or former smokers who stopped smoking <6 months prior to visit 1 (including all forms of tobacco, e-cigarettes, or other vaping devices, and marijuana.
Study Design
Study Start date:
October 05, 2023
Estimated Completion Date:
Study Description
Connect with a study center
Elite Clinical Studies, LLC
Phoenix, Arizona 85018
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.